OR WAIT null SECS
New faces among the Pharma Industry rise the ranks
ROS NT LLC announced today they have appointed Mark Paul as Senior Vice President, US Operations. He will be responsible for the company’s U.S. operation and will represent U.S. interests on the global leadership team. Mr. Paul brings significant experience to the position having served in senior management roles at Quintiles, Health Decisions, StatWorks, and most recently Veracity Logic.
Andrew MacGarvey, CEO of CROS NT, said, “I am delighted to welcome Mark to our company. We are growing our customer base in the United States and increasing the size of our group here. Mark has great experience in delivering global projects and in growing and developing operational teams. He will oversee our continued growth in the region and will work closely with our customers to ensure they receive the highest levels of service”.
Camargo Pharmaceutical Services, a global drug development strategist specializing in the 505(b)(2)approval pathway, has appointed Marc Wiles, Ph.D., as Vice President, scientific and regulatory affairs, and Suzanne Beck, J.D., M.P.H., as director, contracts and legal projects. With more than 20 years of experience in drug development, Wiles brings extensive technical and regulatory expertise to Camargo in assessing, developing and registering therapeutic products. He has demonstrated success across the full life cycle of pharmaceutical product research, development and regulatory affairs in Europe and the United States, with considerable interaction with regulatory agencies.
Ashfield has announced that Clint Burrus will take on the role of Senior Vice President, Business Development for Ashfield Market Access. In this role, Mr. Burrus will be responsible for identifying new business opportunities and ensuring the successful execution of key client projects.
Alliance Life Sciences, a global life sciences consultancy and technology provider, today announces the appointment of Mike Astringer as Director of Talent to shape a “Talent Team” that focuses on internal consulting and service delivery -- not simply administration efficiency and compliance. With 20+ years of experience, Astringer draws upon his considerable experience and knowledge to promote the Alliance employment brand, engage employees and oversee talent acquisition strategies. Teresa Ferlo joins the Alliance team as Vice President of Global Client Development; John Fulton was named Director of Global Client Development;Morayea Pindziak will serve as Vice President of Marketing; and Courtney Klauber joins as Marketing Associate.
ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, today announced the appointment of Steve Nuckols to the position of Executive Vice President and Chief Commercial Officer (CCO). As CCO, Nuckols will be responsible for all global business development activities within ERT, with primary focus on ensuring ERT’s products and services best meet the needs of its global pharmaceutical customers.
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces the promotions of Dr. Günter Stetter and Sibylle Lawson. Dr. Günter Stetter has been promoted to Senior Director of Clinical Operations, Europe, where he is responsible for overseeing the clinical operations for all CTI European offices and work taking place throughout the continent. Sibylle Lawson has been promoted to Assistant Director, Clinical Trials, where she will continue to oversee global clinical studies across a variety of disease indications.
endpoint has promoted Chuck Harris to General Manager. Jonathan Dole, CEO and co-founder of endpoint stated: "We are extremely pleased to announce Chuck's promotion. In this role, Chuck will be responsible for the execution of endpoint's mission to deliver a highly customizable, fully configurable SaaS IRT offering to our global customer base." Chuck has provided quality and operations leadership in the IRT industry for more than 14 years, having most recently served as endpoint's director of product development.
Almac Group, the global contract development and manufacturing organization, today announced the appointment of a new Vice President at its Craigavon and Souderton Headquarter facilities. Dr. John Robson has been appointed Vice President of Quality Operations at its Sciences’ business unit based in the UK, which offers API and chemical development services for all stages of drug development.
Metrics Contract Services (Metrics) has added a new senior formulation scientist to its growing staff of pharmaceutical experts. Among his other duties, Michael R. Mascarenas is responsible for the formulation and process development of early-phase oral dosage forms, and oversees the manufacture of clinical trial materials to support client-sponsored research studies.
Schulman Associates IRB, Inc., a central IRB in customer service and technology, announces the acquisition of Missouri-based Absolute Research. Additionally, Absolute Research founder Rebecca Ballard will be joining the Schulman team as Vice President of Compliance and Board Operations. The transaction allows for significant investment to expand Absolute Research’s innovative technology offerings for the clinical research community, and Ms. Ballard’s substantial research ethics and legal expertise, as well as her leadership experience in the institutional research setting, bring valuable perspectives and knowledge to the organization.
MedNet Solutions, a SaaS-based eClinical technology company that supports the entire spectrum of clinical research, is pleased to announce that iMedNet™, the company's intuitive, flexible and affordable cloud-based eClinical technology platform, has been awarded a Silver 2015 Stevie® Award by the American Business Awards(SM) in the Health Products & Services Website category. The American Business Awards are considered the nation's preeminent business awards program.